The Economics of Innovation: Part II

25 June 2012 Personalized Medicine Bulletin Blog

In my June 10th, 2012 post, I  noted a report on the current debate whether or not patents promote or impair innovation in the diagnostic field.  Last week at the 2012 Biotechnology International Organization (BIO) International Convention, Joseph Damond, vice-president for international affairs at BIO reported the results of a BIO-commissioned study to answer the question whether patents stifle progress when they occur in the early phases of research. Looking at patenting trends in emerging and developed nations, the researchers concluded that the argument that IP (i.e., patents) work against stimulating innovation is quite theoretical. 

BIO engaged Pugatch Consilium, a consulting group based in Israel and the United Kingdom to conduct the study. The Consilium searched publications and databases for associations between intellectual property rights (IPR) and measures of economic development and biotech health. It was reported that neither the literature nor database searches support the perception that IPR stands in the way of research in the biotech and pharmaceutical sectors.

More information on the report can be found at the Nature News Blog.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.